
Sign up to save your podcasts
Or


The Positive Gene Podcast | Hereditary Breast Cancer Series
Sometimes you can look at someone who’s been there and know they understand. You can start with how you feel today without having to explain everything that came before.
At 31, Kelly Kashmer learned she carried a BRCA2 mutation. Just weeks later, her first round of screening revealed stage II triple-negative breast cancer. She’d barely had time to take in what the genetic test meant for her future when she found herself facing the very diagnosis she’d just learned she was at increased risk for.
In this episode, host Sara Kavanaugh welcomes Marleah Dean Kruzel, Ph.D., as guest co-host for a conversation with Kelly about what it feels like to live with hereditary cancer risk, how that knowledge reaches into family life, and why it matters to spend time with people who understand from experience.
Kelly is candid about how disconnected she felt from the familiar pink imagery of breast cancer while going through treatment. She tells the story behind the name NothingPink and how the organization grew as people told her what they needed. The same openness she brings to telling her own story comes through in the way she talks about making room for previvors, survivors, partners, and children to share theirs.
What led to genetic testing. The family history conversation that prompted Kelly to get tested.
From a BRCA2 result to a breast cancer diagnosis. What it felt like to get both pieces of news within weeks.
Living with uncertainty. The emotions that can surface after learning you have an inherited cancer risk.
Being understood without explaining yourself. The connection that can happen between people who’ve been there.
The story behind NothingPink. What inspired the name and what it meant to Kelly.
Building a community around what people need. How the people NothingPink serves helped shape its work.
Making room for the whole family. How hereditary cancer risk can affect the people closest to us.
Kelly Kashmer is the founder and executive director of NothingPink, a nonprofit based in Rock Hill, South Carolina, that supports individuals and families affected by hereditary breast and gynecological cancers. Kelly’s experience with BRCA2 and breast cancer shaped her commitment to helping people understand their risk and find others they can talk with openly. In this episode, she shares how NothingPink connects people across the Carolinas and how virtual options help people stay connected when getting together in person is difficult.
Connect with Kelly on LinkedIn.
Marleah Dean Kruzel, Ph.D., is a health communication researcher, BRCA2 previvor, and co-founder of Previvor Perspectives with Sara. She brings both research and lived experience to this conversation, including how people communicate about uncertainty, make decisions about their health, and talk about inherited risk with family. Connect with Marleah on LinkedIn.
Connect with NothingPink
Learn about NothingPink’s mission and Kelly’s story. About NothingPink
Explore mentorship, community programs, and practical support. NothingPink | Get Support
See upcoming support groups and check whether they meet virtually or in person. NothingPink | Support Group Calendar
Learn about care packages for people preparing for or recovering from surgery. NothingPink | Surgical Care Packages
Additional hereditary cancer resources
Find peer navigation and other resources for people affected by hereditary cancer. FORCE | Hereditary Cancer Support
Search for a genetic counselor to talk through your personal or family history and questions about genetic testing. National Society of Genetic Counselors | Find a Genetic Counselor
Hear Sara and Marleah’s earlier conversation about discussing genetic risk with family, partners, and healthcare providers. Communicating Genetic Risk with Confidence
The Hereditary Breast Cancer Series brings together experts, previvors, and survivors for ten conversations about what it means to know you have an inherited risk of breast cancer. The series explores risk assessment, screening, risk-reducing surgery, and the personal decisions that come with each. This episode makes space for what happens between those decisions, when you’re living with the information and looking for someone who understands.
This podcast is for education and awareness. For guidance on genetic testing, screening, or prevention based on your personal and family history, speak with a qualified healthcare professional or genetic counselor.
Hosted by Sara Kavanaugh
The Positive Gene Podcast | Hereditary Breast Cancer Series
What does life look like after learning you carry a hereditary cancer mutation? And how do you make decisions about your health when you've already witnessed the impact of cancer on the people you love?
In this episode of The Positive Gene Podcast, Sara Kavanaugh welcomes Raychel Kubby Adler, a BRCA2 previvor, author of Life in Asymmetry, and longtime hereditary cancer advocate who now works with FORCE: Facing Our Risk of Cancer Empowered.
Raychel's story begins with her sister Lisa, who was 16 years older and one of the most influential people in her life. After witnessing both her mother and sister face breast cancer, Raychel learned she carried the same BRCA2 mutation as Lisa.
That knowledge gave her choices previous generations of her family hadn't had.
Raychel shares why she ultimately chose a preventive mastectomy, the emotional toll of ongoing surveillance, and the unexpected complications she experienced during reconstruction. Looking back nearly two decades later, she reflects on what she might have approached differently and why she remains grateful for the decisions she made.
But this conversation reaches far beyond surgery.
Raychel discusses how writing became a way to process grief, why she incorporated humor into her memoir, and how sharing family stories keeps the people she's lost present in her life.
Now, as the mother of two adult daughters who are beginning to consider their own genetic testing decisions, Raychel finds herself looking toward the next generation and the possibilities that advances in hereditary cancer care may offer.
Life in Asymmetry by Raychel Kubby Adler
Connect with Raychel
How Raychel's sister Lisa influenced her decision to pursue genetic testing
What it was like to learn she carried a BRCA2 mutation nearly 20 years ago
Why she chose preventive mastectomy rather than continuing high-risk breast surveillance
The realities of reconstruction, surgical complications, and body image
What she wishes she'd understood before making her surgical decisions
How writing Life in Asymmetry helped her navigate grief and preserve her family's stories
The emotional complexity of raising children who may inherit hereditary cancer risk
How her relationship with FORCE evolved from seeking support to supporting others
Why decisions about hereditary cancer risk continue throughout life
One of the most meaningful themes in Raychel's story is that knowing your genetic risk doesn't mean knowing exactly how your life will unfold.
The information can open doors to prevention and early detection, but it also introduces decisions that are deeply personal.
For Raychel, those decisions have been shaped by family history, motherhood, grief, and the desire to be present for the people she loves.
Her experience reminds us that there is no single path through hereditary cancer risk. What matters is having the information, resources, and support to make choices that fit your circumstances.
Raychel is a BRCA2 previvor, author, and hereditary cancer advocate. After finding support through FORCE during her own genetic testing and preventive surgery journey, she became a volunteer and later joined the organization professionally.
Her memoir, Life in Asymmetry, explores family, hereditary breast cancer, preventive surgery, and the unexpected ways humor and hope can coexist with loss.
FORCE: Facing Our Risk of Cancer Empowered
FORCE provides education, support, and resources for individuals and families affected by hereditary cancer risk.
FORCE Post-Mastectomy Photo and Video Gallery
This episode is part of The Positive Gene Podcast's hereditary breast cancer series, exploring genetic risk, screening, prevention, risk-reducing surgery, and the experiences of people navigating these decisions.
Through conversations with medical experts, advocates, and individuals living with hereditary cancer risk, the series aims to make complex information more accessible and help listeners feel better equipped to make informed decisions.
Listen to more episodes of The Positive Gene Podcast:
This podcast is intended for education and awareness and does not replace personalized medical advice. Discuss genetic testing, screening, and risk-reducing options with qualified healthcare professionals.
The Positive Gene Podcast | Hereditary Breast Cancer Series, Episode 2
Knowing you have an increased breast cancer risk brings important decisions. If you choose continued surveillance, what does “watching closely” actually look like?
In the second episode of our 10-part hereditary breast cancer series, host Sara Kavanaugh welcomes Dr. Rachel Brem, a breast imaging radiologist, breast cancer survivor, BRCA1 carrier, and co-founder and chief medical officer of the Brem Foundation.
Dr. Brem shares how her mother’s breast cancer diagnosis at age 33 shaped her career, and how she discovered her own breast cancer while testing ultrasound equipment shortly before a planned risk-reducing mastectomy.
Together, Sara and Dr. Brem explore the considerations behind surveillance and risk-reducing surgery, how different imaging tools contribute to early detection, and why screening conversations should account for your individual risk.
Drawing on her own experience living with a CHEK2 variant and extremely dense breasts, Sara shares the questions that come with choosing surveillance and revisiting decisions as research and personal circumstances evolve.
• How Dr. Brem’s experiences as a daughter, physician, and patient shaped her approach to breast care
Dr. Rachel Brem is a breast imaging radiologist, professor and vice chair of radiology, and director of breast imaging and intervention at George Washington University.
A breast cancer survivor and BRCA1 carrier, she brings both professional expertise and personal experience to her work in early detection and patient advocacy.
She is co-founder and chief medical officer of the Brem Foundation to Defeat Breast Cancer and co-author, with breast surgeon Dr. Christy Teal, of No Longer Radical: Understanding Mastectomies and Choosing the Breast Cancer Care That’s Right for You.
Connect with Dr. Brem and the Foundation:
Breast health education and risk awareness
• Brem Foundation: Education, resources, and information about breast cancer early detection.
• CheckMate: The Brem Foundation’s breast health quiz, available through its website, can help you identify questions to discuss with your healthcare provider.
Breast imaging technology
• Automated breast ultrasound (ABUS): An imaging approach that captures a broad set of breast ultrasound images for a radiologist to review. It uses sound waves without ionizing radiation or injected contrast and may be used as supplemental screening for people with dense breasts.
• BeSound: Dr. Brem discusses this company’s approach to expanding access to automated breast ultrasound. Visit its website for information about services and availability.
Supplemental ultrasound does not replace recommended mammography or a personalized high-risk screening plan. Ask your healthcare team which imaging options are appropriate for you.
Access to breast care
• B-Fund and Wheels for Women: Learn about the Brem Foundation’s programs addressing financial barriers to diagnostic testing and transportation barriers to breast care.
Reading and screening guidance
• No Longer Radical, by Dr. Rachel Brem and Dr. Christy Teal:
• National Comprehensive Cancer Network (NCCN) patient resources:
This episode is part of a 10-part series exploring the medical and personal experiences of living with hereditary breast cancer risk.
Through conversations with genetic counselors, physicians, advocates, previvors, and survivors, we explore risk assessment, high-risk screening, preventive surgery, decision-making, and the emotional realities of living with increased risk.
Our goal is to help you better understand your options, ask informed questions, and work with your healthcare team to make decisions that are right for you.
Start with Episode 1, Understanding Hereditary Breast Cancer Risk with Genetic Counselor, Dena Goldberg, and follow The Positive Gene Podcast so you don’t miss the next conversation.
This podcast is intended for education and awareness only and does not provide individualized medical advice. Genetic risk, screening recommendations, and preventive options vary by individual. Please consult a qualified healthcare professional or genetic counselor about your personal and family history.
Host: Sara Kavanaugh | The Positive Gene Podcast
Website: https://www.sarakavanaugh.com
The Positive Gene Podcast | Hereditary Breast Cancer Series, Episode 1
When we hear about hereditary breast cancer, BRCA1 and BRCA2 are often the first genes that come to mind. But hereditary breast cancer risk is much more complex, and understanding your genetic information can make a significant difference in how you approach your health.
In the first episode of our 10-part hereditary breast cancer series, host Sara Kavanaugh welcomes Dena Goldberg, MS, CGC, a board-certified genetic counselor, science communicator and founder of Malibu Genetics Concierge, also known as Dena DNA.
Dena brings years of experience in cancer genetics, patient education and advocacy to a conversation designed to make genetics more understandable for anyone navigating hereditary cancer risk.
Together, Sara and Dena explore what makes cancer hereditary, why a family history of cancer doesn't always tell the whole story, and what genetic testing can and cannot tell us about our future health.
They also discuss genes beyond BRCA, including CHEK2, ATM and PALB2, the importance of understanding variants of uncertain significance (VUS), and why genetic test results should be interpreted alongside personal and family history.
Drawing on her own experience living with Lynch syndrome and a CHEK2 variant, Sara shares the questions and challenges that can arise even years after receiving a positive genetic test result.
The difference between hereditary, familial and sporadic cancer
Why someone can carry a hereditary cancer mutation without an obvious family history
How breast cancer risk differs across genes and even specific variants
Who should consider genetic testing and how to access genetic counseling
Understanding positive, negative and uncertain genetic test results
The difference between inherited (germline) and tumor (somatic) genetic testing
Sharing genetic information with family members and cascade testing
Building a healthcare team, finding reliable resources and making informed decisions over time
Dena Goldberg, MS, CGC, is a board-certified genetic counselor and science communicator who makes genetics approachable through education, social media and her work with patient communities.
Known online as Dena DNA, she creates educational videos, explainers and resources to help people better understand genetic testing and inherited health conditions.
Connect with Dena:
Instagram: @dena.dna
TikTok: @denadna
YouTube: @DenaDNA
Website / genetic counseling information: https://www.denadna.com/
Genetic testing and counseling
JScreen: https://www.jscreen.org/
JScreen Promo Code: Use code DENADNA to get $10 off your testing kit.
Genetic information and variant updates
ICARE Registry: https://inheritedcancer.net
PROMPT Registry: https://promptstudy.info/ (https://www.genomeconnect.org/)
My Gene Counsel / Living Lab Report: [https://www.mygenecounsel.com/
ConnectMyVariant: https://connectmyvariant.org/
Citizen Genetics: https://www.citizengenetics.co/
National Comprehensive Cancer Network (NCCN): https://www.nccn.org/patientresources/patient-resources
Community support
FORCE (Facing Our Risk of Cancer Empowered): https://www.facingourrisk.org
The Breasties: https://thebreasties.org/
We Got This, cancer gift registry: https://wegotthis.org/
If you're watching the video version, you may notice Sara wearing a genetics-inspired headband from Lilac Market Headbands.
After seeing Dena share the brand on Instagram, Sara ordered the DNA-print design, which arrived just in time for their recording!
Check out Lilac Market Headbands and use code DenaDNA for a discount. Click HERE to order.
This is a product mention inspired by Dena's social media post. No paid sponsorship of this episode is indicated.
This episode launches a 10-part series exploring the medical and personal experiences of living with hereditary breast cancer risk.
Through conversations with genetic counselors, physicians, advocates, previvors and survivors, we'll explore risk assessment, high-risk screening, preventive surgery, decision-making and the emotional realities of living with increased risk.
Our goal is to help you better understand your options, ask informed questions and work with your healthcare team to make decisions that are right for you.
Follow The Positive Gene Podcast so you don't miss the next conversation.
This podcast is intended for education and awareness only and does not provide individualized medical advice. Genetic risk, screening recommendations and preventive options vary by individual. Please consult a qualified healthcare professional or genetic counselor about your personal and family history.
Host: Sara Kavanaugh | The Positive Gene Podcast
Website: https://www.sarakavanaugh.com
Instagram: @positivegenepodcast
As patient advocates, we have the opportunity to help shape healthcare policy by sharing our lived experiences with the people making decisions that affect our lives.
In this episode of The Positive Gene Podcast, host Sara Kavanaugh sits down with Tennessee State Representative Bob Freeman for a candid conversation about how legislation really works, why patient stories matter, and how advocates can help influence meaningful change.
Sara first met Representative Freeman during Susan G. Komen Advocacy Day at the Tennessee Capitol. Walking into those legislative meetings initially felt intimidating, but she quickly realized something that changed her perspective forever: legislators don't just need data. They need to understand how policies affect real people.
Together they discuss:
One of the most powerful reminders from this conversation is that medical professionals are experts in the science. Legislators are experts in the policymaking process. Patients and caregivers are the experts in living with the consequences of those decisions.
Every one of those perspectives belongs at the table.
Whether you've participated in an Advocacy Day before or have wondered if your story could ever make a difference, this episode will leave you feeling informed, encouraged, and empowered to use your voice.
If this episode resonates with you, consider joining an advocacy organization such as FORCE, Susan G. Komen, Fight Colorectal Cancer, or another organization aligned with your cause. Advocacy is often easier - and more impactful - when we work together.
Because meaningful change doesn't happen by accident.
It happens when people show up.
🌐 Website: https://www.sarakavanaugh.com
🎙️ The Positive Gene Podcast: https://thepositivegenepodcast.podbean.com/
📸 Instagram: https://www.instagram.com/positivegenepodcast
💼 LinkedIn: https://www.linkedin.com/in/sarakavanaughspeaks/
▶️ YouTube: https://www.youtube.com/@sarakavanaughspeaks
If this episode encouraged or inspired you, please consider:
⭐ Following or subscribing to The Positive Gene Podcast
⭐ Leaving a rating and review on your favorite podcast platform
⭐ Sharing this episode with a friend, caregiver, healthcare professional, or fellow advocate
Your support helps us reach more individuals and families navigating hereditary cancer risk.
Remember: Knowledge is power. Prevention is possible. And your voice has the power to create meaningful change.
Episode Summary
Sara Champie shares her personal journey after learning she carried a BRCA1 mutation following the loss of her mother to ovarian cancer, and how that experience ultimately shaped her work as a psychotherapist specializing in hereditary cancer and genetic risk. The conversation dives into trauma-informed care, the emotional weight of prevention decisions, the complexity of “being strong,” and why connection and storytelling matter so much in this community.
They also discuss Sara’s podcast, Walking the Genetic Line, which creates space for the deeply human side of genetic testing and hereditary cancer risk.
Follow The Positive Gene Podcast on your favorite podcast platform.
Follow along on Instagram @positivegenepodcast for episodes, advocacy, education, and hereditary cancer conversations.
This podcast episode is intended for educational and storytelling purposes only and should not be considered medical or mental health advice. Please consult your healthcare provider or licensed mental health professional for individualized support.
As we close out Colorectal Cancer Awareness Month, this episode marks the final installment in our series on Lynch syndrome and hereditary cancer risk. If you haven’t yet, I encourage you to go back and listen to the earlier episodes—each one offers a powerful and important perspective on what it means to understand and navigate inherited cancer risk.
****
Diane Hardesty’s story is one that clearly shows what can change when awareness meets action.
Before genetic testing, Diane’s family experienced ten cancer-related deaths connected to Lynch syndrome. Cancer wasn’t a possibility, it felt inevitable.
But once Diane chose to pursue genetic testing, everything shifted.
Through testing, proactive screening, and open family communication, her family has now experienced zero cancer-related deaths.
In this conversation, Diane shares her personal journey, the emotional weight of growing up with cancer as an expectation, and how one decision changed the trajectory for future generations.
This episode is a reminder that understanding your risk doesn’t create fear—it creates options.
Diane’s story is a powerful example of how knowledge can change a family’s future.
If cancer runs in your family, or if those conversations have never happened, this episode is a place to start.
🎧 The Positive Gene Podcast - https://thepositivegenepodcast.podbean.com/
IMPORTANT: This episode is for educational purposes and is not medical advice. Always consult your healthcare team for personal guidance.
This episode is part of a five-part series on living with Lynch syndrome, focused on raising awareness and sharing perspectives from patients, advocates, and organizations working to improve outcomes in hereditary cancer.
In this episode, Sara Kavanaugh speaks with Joan Rush, co-founder of the Jacqueline Rush Foundation, an organization dedicated to raising awareness of Lynch syndrome among both patients and the medical community.
Joan shares the story of her daughter Jacqueline, who was diagnosed with colorectal cancer at just 20 years old after years of symptoms that were dismissed. During treatment, Jacqueline and her family learned the underlying cause was Lynch syndrome.
Although Jacqueline passed away at 23, her story continues to shape awareness, research, and advocacy in meaningful ways.
This conversation highlights:
As Joan shares,
Jacqueline Rush Foundation
Media & Awareness
Lynch Syndrome Conferences (Patient-Focused)
👉 Many sessions offer recordings/replays—check institutional sites for access.
Additional Resource
Jacqueline’s story reflects a time when awareness and options were limited.
Today, the landscape is different.
There are better tools, more research, and more opportunities to prevent or detect cancer early.
This episode is not only about loss. It’s about what is now possible.
If this episode resonates, consider sharing it with:
🎧 The Positive Gene Podcast - https://thepositivegenepodcast.podbean.com/
Lynch Syndrome Series - This episode is part of a five-part series on living with Lynch syndrome, released in recognition of Lynch Syndrome Awareness Day on March 22.
In this episode, Sara Kavanaugh speaks with Jennifer Mercer, founder of Lynch Syndrome Awareness and Education, a nonprofit dedicated to increasing awareness and helping families better understand hereditary cancer risk.
Family history matters more than most people realize.
You have to start the conversation.
Genetic testing provides clarity and direction.
Lynch syndrome is not rare.
Community and connection reduce isolation.
Jennifer’s advocacy began with her own family’s experience. After reconnecting with her biological father, she witnessed him endure multiple primary cancers over decades before genetic testing finally revealed Lynch syndrome.
Following his diagnosis and passing, Jennifer made the decision to pursue testing herself and tested positive for an MSH2 mutation. What followed was not only a personal turning point, but the beginning of a broader mission to help other families avoid the same uncertainty.
This conversation focuses on:
how awareness can change outcomes across generations
why family communication is critical in hereditary cancer
and how community and accessible information can support individuals navigating Lynch syndrome
Lynch Syndrome Awareness and Education
Educational tools, family letters, and resources for newly diagnosed individuals
Community support and upcoming expert webinars
Upcoming Webinar: March 30
This episode is a reminder that hereditary cancer risk does not exist in isolation. It lives within families.
Understanding your history, asking questions, and sharing information can change not only your path, but the path of future generations.
Listen & Share
If this episode resonates, consider sharing it with someone who may benefit—from patients and families to healthcare providers and advocates.
🎧 The Positive Gene Podcast
Connect with Jennifer
Connect with The Positive Gene Podcast
IMPORTANT: This episode is for educational purposes and is not medical advice. Always consult your healthcare team for personal guidance.
Lynch Syndrome Series
In recognition of Lynch Syndrome Awareness Day on March 22 each year, The Positive Gene Podcast is featuring a five-part series exploring what it means to live with Lynch syndrome; from diagnosis and treatment to advocacy, prevention, and long-term survivorship.
Note: This episode includes brief discussion of depression and suicidal thoughts. Please listen with care. Support resources are included below.
Episode Overview
In this episode, Sara Kavanaugh speaks with JJ Singleton, a young adult colorectal cancer survivor and advocate living with Lynch syndrome.
Diagnosed at just 27, JJ shares the experience of noticing symptoms but not initially acting on them, the reality of navigating cancer treatment in a rural setting, and what it meant to later learn his diagnosis was connected to a hereditary cancer condition.
This conversation goes beyond diagnosis. JJ speaks openly about the mental health challenges that came with long-term treatment, including periods of deep depression, and how therapy, connection, and advocacy helped him find a path forward.
Today, JJ uses his experience to support others through advocacy, peer connection, and patient advisory work, helping ensure that the realities of young adult cancer are better understood.
This episode offers both perspective and practical insight for patients, families, and those supporting individuals navigating hereditary cancer risk.
Key Takeaways
Resources Mentioned in this episode:
Mental Health Support
Lynch Syndrome & Hereditary Cancer
Young Adult & Peer Support
Why This Episode Matters
JJ’s experience highlights that hereditary cancer is not limited by age, geography, or expectation.
His voice brings attention to:
Listen & Share
If this episode resonates, consider sharing it with someone who may benefit—from patients and families to healthcare providers and advocates.
🎧 The Positive Gene Podcast
Connect with JJ
Connect with The Positive Gene Podcast
From the publisher's feed